A biotechnology saliva testing firm has partnered with Henry Schein, the world’s largest supplier of well being care options to office-based dental and medical practitioners.
Oral Genome’s mobile-compatible take a look at kits present clinical-grade leads to lower than quarter-hour, with out the necessity for lab processing. The kits analyse key salivary biomarkers linked to situations akin to dental caries, periodontal illness and diabetes.
“Expanded point-of-care testing choices align with our mission to advance prevention and wellness by means of systemic well being fashions, and Oral Genome gives dentists and physicians a robust software to raise care,” Dirk Benson, president of Henry Schein’s U.S. Distribution Group, mentioned in a information launch Tuesday.
Learn associated article: Saliva diagnostics: Pioneering the way forward for dentistry and drugs
Associated: The basics of oral & systemic well being
The partnership will roll out by means of Henry Schein’s distribution channels, focusing on dental practices, group well being clinics and medical workplaces in search of new preventive care strategies.
“Our point-of-care testing equips practitioners with actionable insights, reworking routine visits into alternatives for whole-health advocacy,” mentioned Dr. Tina Noticed, CEO of Oral Genome.
This isn’t the primary time Henry Schein has partnered with a saliva testing firm. In 2024, the corporate introduced it could distribute Viome’s Oral Well being Professional with CancerDetect take a look at, which screens for oral and throat most cancers.
